Theravance Bio: Q2 Earnings Snapshot

August 4, 2022 GMT

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Thursday reported a loss of $8.2 million in its second quarter.

The George Town, Cayman Islands-based company said it had a loss of 11 cents per share. Losses, adjusted for non-recurring costs and restructuring costs, came to 4 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.

The biopharmaceutical company posted revenue of $11.1 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $17.5 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TBPH at